Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004579 · ClinicalTrials.gov registry record · Phase 1
A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection
A Phase 1 study, sponsored by Walter Reed Army Institute of Research (WRAIR).
- Completed
- Registry status
- Phase 1
- Development phase
NCT00004579 is a Phase 1 study that has completed, run by Walter Reed Army Institute of Research (WRAIR).
The verdict
NCT00004579, a Phase 1 study, has completed, sponsored by Walter Reed Army Institute of Research (WRAIR).
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of this study is to see whether an HIV vaccine, ALVAC vCP205, is safe and can prevent HIV infection. The vCP205 vaccine will be tested with another vaccine, gp160MN/LAI-2.
Interventions
- BIOLOGICAL ALVAC-HIV MN120TMG (vCP205)
- BIOLOGICAL gp160 MN/LAI-2
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004579
The ClinicalTrials.gov registry entry for NCT00004579 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Walter Reed Army Institute of Research (WRAIR), which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ALVAC-HIV MN120TMG (vCP205) is the first listed.
NCT00004579 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004579 about?
NCT00004579 is a clinical study titled "A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection". The purpose of this study is to see whether an HIV vaccine, ALVAC vCP205, is safe and can prevent HIV infection. The vCP205 vaccine will be tested with another vaccine, gp160MN/LAI-2.
What is the current status of trial NCT00004579?
This trial is currently completed. It is a Phase 1 study. The study started on 1998-04.
What interventions are being tested in trial NCT00004579?
The interventions under investigation include: ALVAC-HIV MN120TMG (vCP205) (BIOLOGICAL), gp160 MN/LAI-2 (BIOLOGICAL).
Who is sponsoring clinical trial NCT00004579?
This trial is sponsored by Walter Reed Army Institute of Research (WRAIR), which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.